lipid/polymer-formulated nucleoside modified RNA encoding a murine IL-2-albumin fusion protein (BioNTech/TRON)

N/A

Report date: 2025/03/20 15:18:34

Base Information

Drug Namelipid/polymer-formulated nucleoside modified RNA encoding a murine IL-2-albumin fusion protein (BioNTech/TRON)
Drug Alias NamemAlb-mIL2 protein fusion (BioNTech/TRON)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiontech Se
China Registration ClassN/A

Develop Information

Active CompaniesTronBiontech Se
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A